-transparent.png){kind=logo}
We report on seed migration to the vertebral venous plexus after low dose rate prostate brachytherapy with (125)I. A 74-year-old man with T1c N0 M0 adenocarcinoma of the prostate with a Gleason score of 6 (3+3) and prostate-specific antigen level of 14.94 ng/ml underwent interstitial prostate brachytherapy. Six weeks after treatment at the follow-up to determine aftercare a migrated seed was detected in the vertebral venous plexus and a second one in the right lung. No tissue damage around the migrated seeds was documented and the patient exhibited no clinical symptoms.
Related Publications
W Wagner, and
N Willich, and
A Radmard, and
A Christ, and
P W Fleig, and
M G Krukemeyer
January 2006,
Brachytherapy,
W Wagner, and
N Willich, and
A Radmard, and
A Christ, and
P W Fleig, and
M G Krukemeyer
July 2003,
The Journal of urology,
W Wagner, and
N Willich, and
A Radmard, and
A Christ, and
P W Fleig, and
M G Krukemeyer
April 2002,
Urology,
W Wagner, and
N Willich, and
A Radmard, and
A Christ, and
P W Fleig, and
M G Krukemeyer
June 2004,
International journal of radiation oncology, biology, physics,
W Wagner, and
N Willich, and
A Radmard, and
A Christ, and
P W Fleig, and
M G Krukemeyer
January 2012,
Brachytherapy,
W Wagner, and
N Willich, and
A Radmard, and
A Christ, and
P W Fleig, and
M G Krukemeyer
January 2010,
Brachytherapy,
W Wagner, and
N Willich, and
A Radmard, and
A Christ, and
P W Fleig, and
M G Krukemeyer
June 2018,
Prostate international,
W Wagner, and
N Willich, and
A Radmard, and
A Christ, and
P W Fleig, and
M G Krukemeyer
January 2016,
Journal of radiology case reports,
W Wagner, and
N Willich, and
A Radmard, and
A Christ, and
P W Fleig, and
M G Krukemeyer
January 2011,
Brachytherapy,
W Wagner, and
N Willich, and
A Radmard, and
A Christ, and
P W Fleig, and
M G Krukemeyer
August 2004,
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique,
